CRISPR and the Cure Frontier

From Discovery to the World’s First FDA-Approved CRISPR Therapy

Image

Stuart Orkin, MD ’72

David G. Nathan Distinguished Professor of Pediatrics, HMS
HHMI Investigator, Boston
Children’s Hospital
Image

Vijay Sankaran, MD ’09, PhD ’10

Jan Ellen Paradise, MD Professor of Pediatrics, HMS
Visit the Orkin Lab →
Visit the Sankaran Lab →

CASGEVY marked the world’s first FDA approval of a medicine based on CRISPR/Cas9 gene-editing technology, ushering in a new era for sickle cell disease treatment.

Image
Watch: how a genetic insight paired with gene editing technology led to a life-changing new therapy
LOGO